Cagri 5mg
US$65.00
Cagrilintide is a long-acting amylin analog, currently being investigated as a treatment for obesity and type 2 diabetes, often in combination with semaglutide (as CagriSema). It is administered via once-weekly subcutaneous injection and works by mimicking the effects of amylin, a hormone that helps regulate appetite, slow digestion, and control blood sugar levels.